Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,226 public trials 1,176 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT04267848

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 1151 locations
View Trial Details
Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

NCT07094113

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 39 locations
View Trial Details
Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

NCT06498635

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
View all 271 locations
View Trial Details
Recruiting

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

NCT07489066

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +17 more
Locations
  • Hope and Healing Clinical Research Hinsdale, Illinois, United States
  • Hope and Healing Clinical Research New Lenox, Illinois, United States
  • Pan American Center for Oncology Trials, LLC - Manati Office Manati, Puerto Rico
  • Clearview Cancer Institute (Crestwood) Huntsville, Alabama, United States
View all 14 locations
View Trial Details
Recruiting

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

NCT07057791

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Cancer, +8 more
Locations
  • University of Miami Miami, Florida, United States
  • University of Maryland Baltimore, Maryland, United States
  • Morristown Medical Center Morristown, New Jersey, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details
Recruiting

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

NCT06170788

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Mayo Clinic in Arizona - Phoenix ( Site 0147) Phoenix, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0130) Burbank, California, United States
  • Cancer Centers of Colorado St. Mary's Regional Hospital ( Site 0132) Grand Junction, Colorado, United States
  • Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0133) Jacksonville, Florida, United States
View all 220 locations
View Trial Details
Recruiting

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

NCT04165798

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0001) Gilbert, Arizona, United States
  • City of Hope ( Site 0014) Duarte, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0007) San Francisco, California, United States
  • Georgetown University ( Site 0036) Washington D.C., District of Columbia, United States
View all 47 locations
View Trial Details
Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

NCT05920356

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Sansum Clinic Santa Barbara, California, United States
  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center Newark, Delaware, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
View all 404 locations
View Trial Details

Related conditions